A national hemp trade association and a South Carolina-based hemp company have filed a federal lawsuit against the Drug Enforcement Administration (DEA), challenging a rule the agency implemented last month that could have far-reaching consequences for the U.S. hemp industry.The DEA’s interim final rule clarifies that all hemp derivatives or extracts exceeding 0.3% THC shall remain Schedule I controlled substances. This could be interpreted to include intermediate hemp derivatives that temporarily exceed 0.3% during processing, but contain less than 0.3% in final products. As such, it improperly establishes the DEA’s authority over legal hemp activities, which is contrary to the plain language and intent of the 2018 farm bill, according to the petitioners.Learn more: https://www.votehemp.com/press_releases/hemp-industry-members-file-lawsuit-against-dea-challenging-rule-that-could-have-far-reaching-consequences/